Skip to main content

and
  1. No Access

    Article

    Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors – first 10 years of prospective donor follow-up of Swiss donors

    Since July 2007 prospective life-long follow-up (FU) for unrelated (URD) and related donors (RD) is mandatory in Switzerland and data on every allogeneic haematopoietic progenitor cell (HPC) donation are colle...

    M. Rüesch, S. Amar el Dusouqui, E. Buhrfeind, A. Buser in Bone Marrow Transplantation (2022)

  2. No Access

    Article

    Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation

    Return to work is critical goal following HSCT. However, late effects may impede return to normal activity after HSCT. In the case of inability to work, patients may need a work disability pension to ensure a ...

    A Tichelli, S Gerull, A Holbro, A Buser, G Nair, M Medinger in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    Numerical impairment of nestin+ bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML

    The nestin+ perivascular bone marrow (BM) stem cell niche (N+SCN) may be involved in GvHD. To investigate whether acute GvHD (aGvHD) reduces the number of N+SCN, we examined patients with AML who had undergone al...

    M Medinger, W Krenger, A Jakab, J Halter, A Buser, C Bucher in Bone Marrow Transplantation (2015)

  4. No Access

    Article

    Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT

    The objective of this prospective cross-sectional case-control study was to examine the prevalence of dryness symptoms and its impact on quality of life (QoL) among very long-term survivors after hematopoietic...

    T Daikeler, M Mauramo, A Rovó, M Stern, J Halter, A Buser in Bone Marrow Transplantation (2013)

  5. Article

    Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation

    The clinical characteristics of human metapneumovirus (hMPV)-associated lower respiratory tract infection (LRTI) after allogeneic hematopoietic stem cell transplantation (HSCT) is not well described. We descri...

    A. Egli, C. Bucher, A. Dumoulin, M. Stern, A. Buser, L. Bubendorf, M. Gregor in Infection (2012)

  6. Article

    Erratum: Prognostic impact of iron parameters in patients undergoing allo-SCT

    Correction to: Bone Marrow Transplantation (2012) 47, 60–64; doi:10.1038/bmt.2011.13 Since the publication of this article, the authors have noticed that GN Bazuaye's name was spelt incorrectly. The correct au...

    G N Bazuaye, A Buser, S Gerull, A Tichelli, M Stern in Bone Marrow Transplantation (2012)

  7. No Access

    Article

    Prognostic impact of iron parameters in patients undergoing allo-SCT

    Iron overload contributes to increased transplant-related mortality, and serum ferritin is typically used to detect iron overload. Other iron parameters have received limited attention. We studied serum ferrit...

    G N Bazuave, A Buser, S Gerull, A Tichelli, M Stern in Bone Marrow Transplantation (2012)

  8. No Access

    Article

    Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT

    Hematopoietic SCT (HSCT) after non-myeloablative conditioning is associated with reduced TRM, and increased risk of graft rejection. Although preclinical data have shown the importance of post transplant immun...

    S Gerull, C Arber, C Bucher, A Buser, A Gratwohl, J Halter in Bone Marrow Transplantation (2011)

  9. No Access

    Article

    Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT

    BU–CY is the established non-TBI-based myeloablative conditioning regimen for allogeneic hematopoietic SCT. However, liver toxicity and hepatic veno-occlusive disease (VOD) are frequent life-threatening compli...

    N Cantoni, S Gerull, D Heim, J Halter, C Bucher, A Buser in Bone Marrow Transplantation (2011)

  10. No Access

    Article

    Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?

    Allogeneic hematopoietic SCT (HSCT) is increasingly considered an option in refractory or relapsing lymphoma. Today, most patients with B-cell lymphoma are treated with the monoclonal anti-CD20 antibody rituxi...

    A Buser, M Stern, C Arber, M Medinger, J Halter, A Rovo in Bone Marrow Transplantation (2008)

  11. Article

    Leukemia cutis preceding systemic relapse of acute myeloid leukemia

    M. Stern, J. Halter, A. Buser, A. Rovò, S. Dirnhofer in International Journal of Hematology (2008)

  12. No Access

    Article

    Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment

    C Arber, A Buser, D Heim, M Weisser, A Tyndall, A Tichelli in Bone Marrow Transplantation (2007)

  13. No Access

    Article

    Ressourcen- und Schadstoffmanagement in der Abfallwirtschaft: Die steigende Bedeutung der Recyclingprozesse am Beispiel der bromierten Flammschutzmittel

    Für das Beispiel der bromierten Flammschutzmittel (BFS), einer Klasse von Substanzen, die sehr wertvolle Material-Eigenschaften besitzen, deren Vertreter aber als zukünftige POP-Substanzen gehandelt werden, wi...

    L. S. Morf, R. Taverna, A. Buser in Österreichische Wasser- und Abfallwirtschaft (2007)

  14. No Access

    Article

    Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants

    We studied occurrence, risk factors and outcome of patients with transplant-associated microangiopathy (TAM) after allogeneic stem cell transplantation (HSCT). A total of 221 consecutive patients were transpla...

    M T Martinez, Ch Bucher, G Stussi, D Heim, A Buser in Bone Marrow Transplantation (2005)

  15. No Access

    Article

    Status febrilis mit Bewusstlosigkeit

    Eine zerebrale Beteiligung bei Malaria mit Plasmodium vivax ist ungewöhnlich. Diese schwere Form der Malaria ist üblicherweise durch Plasmodium falciparum bedingt. Wir berichten über eine 18-jährige Patientin ...

    M. Sawatzki, C. Hatz, A. Buser, Prof. Dr. M. Battegay in Der Internist (2005)

  16. No Access

    Chapter and Conference Paper

    Photodynamische Fluoreszenzdiagnose: Technische Konzepte für die klinische Anwendung

    Die Photodynamische Fluoreszenzdiagnose ist ein lasergestütztes Verfahren zum Nachweis von Tumoren im Frühstadium und zur Abgrenzung sichtbarer Tumoren von der scheinbar gesunden Umgebung. Es basiert auf der D...

    P. Heil, R. Baumgartner, A. Buser, D. Jocham in Laser in der Medizin / Laser in Medicine (1992)

  17. No Access

    Chapter and Conference Paper

    First Clinical Experiences with Photodynamic Fluorescence Diagnosis in Urology

    The diagnosing of early stage cancer on the basis of detection of systemically applied fluorescing porphyrin compounds is attracting growing interest. Porphyrin derivative-induced fluorescence was initially us...

    R. Baumgartner, A. Buser, M. Kriegmair, H. Lenz, H. Stepp in Investigative Urology 4 (1991)